Charity reglstration nunTrber 1090822
Company r*glstratlon number 04312822 (England and Walès)
PRO CANCER RESEARCH FUND
{A COMPANY LIMITED BY GUARANTEE)
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2022

PRO CANCER RESEARCH FUND
{A COMPANY LIMITED BY GUARANTEE)
LEGAL AND ADMINISTRATIVE INFORMATION
Trustees
rs Gonul Salih
Professor Chris Foster
Prof8ssor Mustafa Djamgoz
Secretary
Mrs Sabire Dj8mgoz
Charily number
1090822
Company number
04312822
Registered office
9 Park View Road
London
N3 2JB
Indèpèndènt ￿aMiner
KLSA LLP
Kalamu House
11 Coldbath Squa
London
EC1R 5HL
Bankers
Naliansl Wèstmlnster Bank pk
Addiscombe Branch
209 LowerAddiscombe Road
Croydon
United Killgdom
CR9 6RB

PRO CANCER RESEARCH FUND
(A COMPANY LIMITED BY GUARANTEE)
CONTENTS
Page
Tru$18es Report Teport
Independent examinerfs report
Stalernenl o[finan￿al acti￿]11e3
Balan¢e sheet
oles lo fhe financial slalemenls
7-10

PRO CANCER RESEARCH FUND
{A COMPANY LIMITED BY GUARANTEE)
TRUSTEES REPORT REPORT (INCLUDING DIRECTORS, REPORT AND STRATEGIC
REPORTI
FOR THE YEAR ENDED 31 OCTOBER 2022
We are pleased lo present our rèpori togelher with the financial slalemenls of the charily foi the year ended 31
October 2022.
The financial statements have been prepar@d in accordance with the accounting policies sel OLfl in note I lo the
financial statements and comply with the Charity's Aol 2011, the Companies Act 2006 and "Accounting and
Reporting by Charities,, Slalemenl ol Recommended Pia¢tice applic2ble lo tharities preparing their accounts in
accordance with tho Finaniaal Reporting Standard applicable in the UK and Rèpublic of Irèland IFRS 1021 (as
amended for accounting periods commencing from 5 October 20181. The Charity Is a publ1¢ Benefit Entity as
defined by FRS 102.
Patient Support Group/Amher Care Centro
The patsenl Support Group has not bean active for some years and the balance of ils bank acwunl w25 transferred
to Ihe charity's maill account. In order lo streamline the charily's financial burden. the sUPPOrt Celllre also closÈd its
doors. However, Professor Djamgoz continues lo support patients diredly.
Oblectives and activities
Research on MÈtaststl¢ Can¢er$ (Prostate. Breast and Colorectsll wÈth th8 ovèrall stratagy of 'can¢er
neuroscience..
Professor Ojamgoz Telired from active 8¢ademia in February 202Q but has been appointed Emerilus Professor at
Imperial College London. He doos not cu¥rently have his own lab bul continues doing cojlaboralive iesearch al
Imperial and internationally. During 2021-22. 6 résearch papers were published which acknowledged the support of
PCRF.
Strategic report
The desoriplion under the headings'Aehievements and performan¢e" and"Flnancial revievl, meet the company law
requirements for tho Trustees to present a strategic report.
Achievements and perfomiance
Professor Djamgoz supported patients in the following ways..
Help in understanding diagnosis and trèatment..
2. Nulrilional support.,
3. Signposting lo the necessary hosptlals or support organlzallons., and
4. Help patients in accessing treatments.
Financlal review
The charills incoming resources ft>r the year amounted lo £7,34312Q21.. £241. £2,156 <2021.. £2,232) was S￿nI (
charitable actiwlies and £nil (2021.. £901 c>n fundraising activities. £22,516 was received frotll IFnperial College.
which is the refund against the doublé paym6nt made 2 May 2Q19 leamng the charity wlh funds ￿rrIed forward
a8 al 31 October 2022 01 £57,661 12021." £29.9581.The truslees are pleased wlh the financxal perf0mlan￿ of tha
charity during thè year and its financial position al the balance sheet dale.
Over the years, the funds were restricted to make sure that the charity always had ènough funds to eonlinue the
special Fellowship created. As explained in the Annual Report. the charity has been goinq through a transit￿n since
Fèbruary 2020 whereby we have not aGtively been supporting major research. Con8&quently, with big dèm8nd
our ￿$oUrceS and regular income ￿nSIderablY rèducèd. WÉ would release Ihe restricted funds. We will ffom time
give some small grant5 but Ihere is no longèr ¢X)mmilmént for règular support for major research.
The charity relies on donations and grants from indivNJuals and inslitulions, together with fundraising events.
Amounts re￿iVed during the yèar under èach heading are shown in the notes lo Ihe aC￿UnIs.

PRO CANCER RESEARCH FUND
(A COMPANY LIMITED BY GUARANTEE)
TRUSTEES REPORT REPORT (INCLUDING DIRECTORS. REPORT AND STRATEGIC
REPORT) {CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2022
Prlnelpal rlsks and uncèrtainties
Risks are re￿@Wed by the Board of Trustees and appiopriate processe8 put in place lo monitor and mitigate them.
Key risks affecting tho Charity are set out below..
Reputational rlsk- Reputalional darnage lo the Charity may arise from adverse publialy for 8 number of reasons,
including errors or bias in research reports, poor decision m8king or misconduct by Ihe Trustees, involvement of
regulators or aclions taken by staff. Trustees rely on Iheir recruilmenl, indu¢lion and Irdining of Trustees policies to
rniligale this risk.
Financial risk:
Liquidity risk - The Gharily seek8 to rnanagc finanoial risk by 8nsuring suffieianl liquidity is available lo meet
foreseeable needs by moniloring Ihe working capi(al requtremenls.
Regulatory or compliance risks Compliance risk may arise if the Chaiily fails lo comply with Charity Commission
or HNIRC requiiefflenls. Thls may lead to adverse publicity, censure or penalties, and as a result may lead lo
reduced lulure operations. These risks aré Mitigated by the active management of the Charily'8 affair8 by
appropriately qualified legal and finall￿ staff employed by Ihe Trustees.
Risk Management
The Trustees have adopted the followlng risk managemenl stralegy..
an annual review of the risks that tha charity may face.,
establishmenl of system5 and proeÉdurès to mitigate those risks identified in the plan,. and
the implementation of procedures dÈsignèd to Minimise any KM)tenlial impacl on the oharily
should thos& risks materialise.
Going concern
The board has assessed the going ¢onogtn of Ihe charily in detail as stated in note 1 and 1$ confidÈnl that the
charity will have adequate resources lo conlinue in operational existence lor the foreseeable future.
Plan5 for future perlods
There are currently no specAfic plans for the future. Howgver, lollowing the current consolidat￿n period, the Iruslees
will meet lo have a disctjssion about the way forwaTd. In the meantime, Ihe chatity will continue giving small grants
to key projects.
Structure. governance and management
The organisalion is a charitable company1Smit6d by guarantee, ineorporated on 29 October 21J07 and iegislsrgd as
a charity on 27 February 2002. The comp8ny was established under a Memorandum of Association, which
eslablished thé objects and powers of the ohaiilable cotnpany. and is govemed under ils Articles of Association. In
the event of the company bein9 wound up, members are required lo contribut8 an amount not axceeding £1.
The Trustees, who are also the 4Jirectors for the purpose of company law. and who served durtng the y&ar and up to
the dale of signature of the financial statéments were..
Mrs Gonul Salih
ProfessoT Chris Foster
Professar Mustafa Djamgoz

PRO CANCER RESEARCH FUND
(A COMPANY LIMITED BY GUARANTEE)
TRUSTEES REPORT REPORT (INCLUDING DIRECTORS, REPORT AND STRATEGIC
REPORTI (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2022
Thè dirèctors of the company ale also its trustees for the purpose of charfty law and IhroLFghout this report are
collectively ielarred to as t¥uslees. The Board of Trustees is responsible for the overall governance of the charity.
Palenlial new Iiuslee5 are nominaled by an exi8tsng trustee and then appointed 8fteT a Vote by all Ihe trustees. We
have just appointed a new trustee and are in the wocess of recruiting another.
Effective partnership between thè staff and Ihe board of tiuslee8 and regular updates on the actiwlies undertaken is
vital lo the effective managerllenl of the Charity. We are always exploring nèw ways that can improve this even
more. Thè trustees will attempt lo meet quarterly and are notified by email of any signfficanl developmonls in
between thè méetings. We are considering rnore f￿qUellt meetings and more regulaT wrillell updates and are
looking lo improve all our reporting guidelines as the charity is now growing and changing.
The Board delegates the exei¢i88 of certain powers in connection wllh the management and administration of the
charily as sel out further below. This is eontmlled by requiiing regulaT reporting back to the Board and having a
Iiuslee who is also involved in the day lo day running of the charily.
The Trustees Roport report, induding the slralÈgic réport. was approved by the Board of Trustees.
Profes8or ￿USta(a Ojamgoz
25 July 2023

PRO CANCER RESEARCH FUND
(A COMPANY LIMITED BY GUARANTEE)
INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF PRO CANCER RESEARCH FUND
I rèport on the finanGial statèments of the Charity lor the year ended 31 October 2022, which are set out on
pagès 5 to 10.
Respecllve responsibilltles of TNsteÈs and examlner
The Charily's Trustees. who arè also Ihe diieelors of Pro Can￿r Research FLSnd for the purposés of company
law, aré r6sponsiblo for the preparalion ol th8 financial 61alemenls. Thè Trustees consider Ihal an audit is not
required for this year under section 144121 ol the Charities Act 2011 {Ihe 20fj1 Acll and that an independenl
éxamination is need8d.
Having satisfied myself that th8 charity is not subject lo audit under CL>mpany law and is eligible foi independent
examinalion, il is my rèsponsibility to..
èxamine the finanual slatémenls under section 145 of the 2011 Act.,
1111 lo lolbw thè proceduros laid dowr) In the geller81 Direciions given by the Charity Commission under seellon
14515llbl of the 2011 Act- and
liiil to slate wh¢lher partIC￿l8r matter8 h8v8 come to my attention.
Basis of Independent axamine¢s report
My oxaminalion was carried out in accordanTr with the general Diroclions given by the Charity Commission. An
examination includes a review of the accounllng iecoTds kept by the charity and a Gomparison of the finanoial
statements presented wlh those records. 11 also includes consideration of any unusual items or disdosures in thé
financial slaleinents, and seeking explanations from you as trltslees cOn￿rning any such matters. The
prO￿dureS underlaken do not provide all the evideDGe that would be required in an audit and consequently no
opinion is givon as lo whether the f￿an￿81 slalemenls present a 'lrue and fair vi￿, and the report is limited lo
those malleis sét out in the next statement.
Independent examiner's statemènt
In cont)6ctson with my examination. no mattèr has come lo my attention.,
{a} which gives me reasonable cause lo believe that in any material iespecl requirernents=
{il lo keep accounling records in accord8n¢e with section 386 of the Companies Ael 20C6,' and
(ill to prepare financial statements which accord with the accounting records. comply with th6 accounting
requirements of section 396 01 the Companies Act 200e and with the molhods and principles of the
Statement of Rècommended Practice.. Accounting and Reporting by Charities.,
havÈ not been met or
Ib) lo Wh￿h, in my oiinion, attention should be drawn in ordw lo enable a proper undorslanding of the
rillan¢ial slalemènts to be reached.
Shilpa Chheda FGA FCCA
KLSA LLP
Chartefed Acwuntanls
Kalarnu House
11 Coldbath Square
London
EC1R5HL
Dated.. 25 July 2023

PRO CANCER RESEARCH FUND
(A COMPANY LIMITED BY GUARANTEE)
STATEMENT OF FINANCIAL ACTIVITIES
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 OCTOBER 2022
Unrestri¢tèd Unrestricted
fullds
funds
2022
2021
Notes
Income from..
Donalions and legacles
Inveslmenls
7.292
51
24
Total Income
7,343
27
endlture on:
Raising thnds
go
Charitable a¢liwties
120,3601
2,224
Total expenditure
{20,360)
2,314
Nat incomellexpendaturel for the yearl
Net movèment In funds
27.703
12.2871
Fund balan¢es at 1 Novèmber 2021
29,958
32,245
Fund balances at 31 October 2022
57,661
29,958
The stat8ment of finan￿31 activiiies Indudes all gains and lo¥ses recognised in the year.
All income and expenditurè derive Irom continuing adlvilies.
The statement of financial activities also Compl￿S with the requiremenls for an incomé and expenditure account
under th& Companies Act 2006.

PRO CANCER RESEARCH FUND
(A COMPANY LIMITED BY GUARANTEE)
BALANCE SHEET
AS AT31 OCTOBER 2022
2022
2021
Not88
Current assets
Cash al bank and in hand
59.774
32,071
Creditors: amounts falling due withln
one year
10
12.113)
12.1131
Net current assets
57,661
29,958
Income funds
Unrestricted funds
57,661
29,958
57.661
29.958
The compally is entilled lo IhÈ èxemption from the audit requirement conlainÉd in section 477 of the CoMpan￿S Act
2006, for the year ended 31 October 2022.
The dlrectors acknowladge their responsibilities for complying with the requirements of the Companies Act 2006
with respect to acrAJuntino records and the preparation ol financial ststements.
The members have not required the Gompany lo obtain an 8udil of its financial sialemenls for the yeaT in question in
accordance with section 476.
These financial slalernenls have been prepared in aithrdance wlth the Pro￿lS5onS applicable lo companies subje¢t
lo the sm811 companies regim8.
The financ4al slatemen18 weie approved by the Trustee8 on 25 July 2023
Professor Musiala Djatngoz
Trustee
Company reglstration numbor 04312822

PRO CANCER RESEARCH FUND
{A COMPANY LIMITED BY GUARANTEE)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2022
Accounting policios
Charlty Informatlon
Pro Cancer Research Fund is a private company limited by guarantee incorporated in England and Wales.
Thè règistèréd officé is g Park V18w Road, Lot)don, N3 2JB.
1.1 Accounting convention
Tho financial slalernonl8 have been prepared in a¢Gordance with the Charity's tgoverning documenll, the
Companies Act 2006, FRS 102 The Finan¢ial Reporting Standard applicable in ihe UK and Republic of
Ireland ('FRS 102°) and Ihe Charities SQRP "Accounting and Reporting by Charities.. Statement of
Recommended Practice applicable to Gharities prep2ring their accounls in accordance with the FinancK21
Rèporting Standard appli2Abl6 in the UK and Republio of Ireland IFRS IC121" (effective l January 20191. The
Charity is x Public BètiÈfit Entity as d6fined by FRS 102.
The Charity has taken advantage of th8 provisions in the SORP for chaTities not lo prepare a Slalernenl of
Cash Flows.
The financial stslernenls are prepared Sn slerling, whlch is the functional currency tsf the Charity. Monetary
amounts in Ihose financial slalernenls are rounded Its the nearest £.
The finanual slalements have been prepared under the histori￿1 cost convention. Imodified to include the
revaluation of freehold propertses and to include investment properties and ￿rtain financial instruments at fair
Valuel. Thè principal accounl'ng policies 2dopl6d are set out below.
1.2 Going concern
At the lime of approving the financi81 slalemènts, the TruslÈ8s havè 8 ￿asOnable èxpéctation that th8 Charity
has adequate resources lo continué in tspèrational Èxistencè for thè for@sèèablÈ luturè. Thus the Trustè8S
conts'nue lo adopt the going con￿rn basis ol accounting in preparing the finar)¢ial st81ements.
1.3 Charitable funds
Unresliicled funds are avallable for use al the discretion of the Trustees In furtherance tsf their tharilable
objectives.
Restl￿ted funds are subject lo specific ¢ondilions by donors as lo how they may be used. The PLtrposes and
uses of the reslricled funds are s81 out in the notes lo the finanoial statements.
Endowment funds are subject Its sp8uli¢ conditions by donors that the capital musl be mainlained by the
Charity.
.4 Income
Income is iecognls8d when the Charity is legally èntitled to it after any performance condftions have been
met, the amounts ¢an be méasured réliably, and it is probablè thal income will be ree£ivèd.
Cash donations are recogniséd on racèipt. Other donations aré recognisèd once thè Charity has been notified
of the donation, unless performaneè Conditions requirè deferral of th6 amount. Ine£>me tax recoverable in
relation to donations re￿¢Ved under Glft Ald or deods of covenant Is recognlsed al the lime of the donation.
Legacies are recognised on re￿Ipl or otherwise if the Charity has been nolilied of an impending dislribulion,
the amounl is thown. and receipt is expected. If Ihe amount is not known. the legacy 13 Iiealed as a
contingènt assel.
1.5 Expendltsjre
Expenditure is accounted for ¢Trn an awru81s bas18 and has been classified under headings Ihal agoregale all
costs ielated lo the category. Wher9 Costs cannot be diTe¢lly attdbuled lo particular headings Ihéy hav8 been
allocaled lo aciivities on a basis consislenl with the use of resources.

PRO CANCER RESEARCH FUND
{A COMPANY LIMITED BY GUARANTEE)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2022
Accountlng policies
Icontinuedl
1.6 Cash and cash equivalènts
Cash and cash equivalents includé cash in hand, deposits held at call with banks. other short-term liquid
investments wilh original maturities of three months or less, and bank overdiafts. Bank overdiafts are shown
within borrowings in current liabililies.
Basle financial assels
Basity financial 8ssels. which indude dèbtors and cash and bank balan￿s, arè initially moasured al
transaction pricA tnduding transaction c051s and dre subsequently carried at amortised cost using tho effective
inloresl method unless the arrangemenl constitutes a financing transaction, where the transactson is
measuiéd at the present value ol the future receipts discounted al a market rate of interest. Financial assets
dassified 88 receivable within one year are nol amortised.
Dérécognitlon of flnancial assets
Financial assÈts are derecognised only when the contractual rights lo the cash Ilows from the asset expire or
are sellled. or when the Charily Iransfers the financial asset and sub51antially all thè risks and rewards of
ownership lo allolher entity, or il some signrfiGant risk.$ and rewards of ownership are rglained but control of
the assél has transferied to another party that is able to sell the assel in its èntirety lo an unrtlated third party.
Basic financial liabilities
Basic financial liabililio8, including ueditors and bank loans are Initially recognis8d at transa¢Uon price unlèss
the arrangement consltLules a financing transaction, where the debt instrumènt is measured at the pr&sent
value of thè futur& payments discounted at a mark2t rate of inteiesl. FinancAal liabilities classified as payable
within one year are not amortised.
Debt Inslrument8 aré Slfbsequenlly carried at amortised cost, using the efforAive interest rate method.
Trade CTeditors are obllgalions lo pay for goods or serv￿Q$ that have been acq(tiied in the ordlnary couisa ol
operations from suppliers. Amounts payable are classified as current liabilities if payment Is due wilhill one
year or legs. If not, Ihoy are presenl8d as n0￿current liabilities. Tfade ctedilors are recogllised initially 81
Iransaciion pri¢e and subsequently measured al amorhsed cost using the effective interest method.
1.7 Employèe benefits
The cost of any unused holiday entitlemet)t Is recLyJni88d in the period in which thè 6mployee's senrices are
received.
Termination benefits are recognised immediately as an expense when the Charity is demonstrably commilted
lo temiinatè Ihe employment of an etnployee or to prowde te¥minalion benefits.
Critical accounting estimates and ludgem8nts
In the application of thè Charily's aceounling poliryes. Ihe Trustees are rgquired lo mak6 judgements,
èstimates and assumptions about th8 carying amount of assets and liabilities that are not readily appaiellt
Irom other sources. The e81irnates and associated assumptsons are based on historical experience and olheT
factors Ihat are cc>nsidered lo be relevant. Aolual ¥esulls may differ frorn these estimatès.
The estimates and undwlying assumptions are reviewed on an ongoing basis. Rovisions lo acct)unting
eslimales are recognised in the period in which the estimate is revised where the rewsion affects only Ihat
period, In the period of Ihe revision and futurè periods where the re￿slon affecis both currenl and future
periods.

PRO CANCER RESEARCH FUND
(A COMPANY LIMITED BY GUARANTEE)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2022
Donations and legacies
Unrestricted Unr•stricted
funds
funds
2022
2021
Donations and gifts
7,292
24
Invèstments
Unrestricted Unrestricted
funds
funds
2022
2021
Interest receivable
51
Rai$lng funds
Total Unrestricted
funds
2022
2021
Fundraisin
and ubSieit
Stagino fulldraising events
90
90

PRO CANCER RESEARCH FUND
{A COMPANY LIMITED BY GUARANTEE)
NOTES TO THE FINANCIAL STATEMENTS {CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2022
Charitable activities
Charitable Charitable
Exponditurè Expenditur&
2022
2021
Accountancy Fees
Bank charges
Sundry Expenses
Resear¢h gr8nl- Imperial College
2,113
1,496
28
700
(22,5161
(20,3601
2,224
120,3601
2,224
TYusteèS
None of the Trustees {or any persons connected with Iheml re￿iVed any remuneration or benefits from the
Charily durtrng the year.
Employees
The average monthly number of employees during Ihe year was..
2022
Numb9r
2021
NumbeT
Total
There were no employees whose annual remuneration was more than £60,1100.
Taxation
The charity is exempl from tax on income and gains falling within section 505 of the Taxes Aci 1988 or section
252 of the Taxalionof Chargeabta GainsAct 1992 lo Ihe exlent that these are applied lo its charitable objects.
10 Creditors: amounts falling due within one year
2022
2024
Accruals and deferred in￿1￿8
2,113
2,113
10-